Eight Ohio biomedical companies have received a total of $8 million in grants from the state’s Third Frontier technology support program. The grants, which awarded about $1 million to each firm, are aimed at accelerating the growth and development of Ohio’s burgeoning biomedical industry, which saw its number of jobs grow by 20 percent during […]
Plans for a new, small, state-backed investment fund that would’ve been operated by Cleveland-based venture development group JumpStart were shot down earlier this year by the state’s Third Frontier program. But JumpStart and the lead investor in the fund, which would be called Euclid Ventures, haven’t given up on the fund and are exploring options […]
The state of Ohio has unveiled plans for an 11-week summer competition that’s designed to attract and retain young entrepreneurs and help them set up businesses in the state. The program, called Ohio’s New Entrepreneur (ONE) Fund, calls for grants of $20,000 to 10 teams of up to five young people. During the competition, aspiring […]
Northeast Ohio's largest angel investor group, North Coast Angel Fund, is nearing an $8 million close on its second fund.
Public-private venture investment group CincyTech plans to invest $3 million in Southwest Ohio startups this year. The vast majority of its portfolio companies are in the biomedical, information technology and alternative energy industries.
Ohio's Third Frontier technology acceleration program has awarded $25 million to several early stage investment funds in the state. The grants come under two different Third Frontier programs, which are designed to funnel growth capital to young, promising technology companies through professionally managed investment funds.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Northwest Ohio venture and business development group Rocket Ventures is looking to invest about $8 million in early stage companies this year. The majority of those investment dollars are expected to go to startups in two industries -- bioscience and alternative energy.
A company that was once the poster child for the joys of living and doing business in Ohio now may have become a cautionary tale about a weakness in the state's much-celebrated Third Frontier program.
Most people in Ohio's biomedical industry would've considered 2010 a good year if just one key thing happened -- voters renewed the state's $1.35 billion, 10-year Third Frontier program, which is designed to energize Ohio’s economy by investing in cutting-edge technology. It happened and heads up MedCity News' list of the biggest highlights of the year for Ohio's biomedical industry.
Early stage investment group North Coast Angel Fund is raising money for a second fund, having pulled in commitments for $800,000. In all likelihood, North Coast Angels are looking to raise $8 million for the group's second fund.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
When it comes to keeping smiles on the faces of Ohio's medical industry leaders, Governor-elect John Kasich's predecessor did him a big favor. It's called Ohio Third Frontier.
Chris Coburn is the captain of Cleveland Clinic Innovations, the corporate venturing arm of the Cleveland Clinic. The 53-year-old fitness enthusiast and his crew have an important job: nurturing inventions that emerge from several thousand scientists and doctors at the nation's top heart hospital, and guiding them through a years-long process to commercial viability, according to the Cleveland Plain Dealer.
The Austen BioInnovation Institute in Akron has received a $2.6 million Ohio Third Frontier grant for biomedical sensor research and commercialization. The grant is from the revamped Wright Center for Sensor Systems Engineering at Cleveland State University.
Who would have thought a smart nanotechnology material that keeps aircraft and wind turbine blades free from ice could help glaucoma patients? Khalid Lafdi and Ed Timm did. At the University of Dayton, the two used Lafdi's invention of "fuzzy fiber" to design a drain tube for glaucoma patients.
Credit for this blog post should really go to William Hoffman, an editor and writer with the University of Minnesota medical school and author of “The Stem Cell Dilemma.” Hoffman e-mailed me after reading my post on how the Democratic candidates for governor rank on biosciences. He specifically focused on the idea that Minnesota’s high […]
